Back to FARALLON CAPITAL MANAGEMENT, L.L.C.

ENTA
Showing 8 of 30 quarters

Position history for FARALLON CAPITAL MANAGEMENT, L.L.C.'s holdings in ENANTA PHARMACEUTICALS INC

FARALLON CAPITAL MANAGEMENT, L.L.C. holds 2.9M shares of ENTA (ENANTA PHARMACEUTICALS INC), worth $36.3M as of 2026-Q1. The position was increased (+3.6% shares). ENTA represents 0.2% of FARALLON CAPITAL MANAGEMENT, L.L.C.'s portfolio.

Current Value

$36.3M

Current Shares

2.9M

Total Value Change

+$9.1M

Total Shares Change

+776,862

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
2.9M
+3.6%
$36.3M0.2%$14.72
36
2025-Q4
Increased
2.8M
+30.6%
$43.7M0.2%$15.90
44
2025-Q3
Unchanged
2.1M
0.0%
$25.4M0.1%$15.16
0
2025-Q2
Unchanged
2.1M
0.0%
$16M0.1%$7.50
0
2025-Q1
Increased
2.1M
+0.7%
$11.7M0.1%$5.71
28
2024-Q4
Unchanged
2.1M
0.0%
$12.1M0.1%$5.85
0
2024-Q3
Increased
2.1M
+0.6%
$21.8M0.1%$10.05
34
2024-Q2
Unchanged
2.1M
0.0%
$27.2M0.1%$12.97
0

Other major holders of ENTA: NORTHERN TRUST CORP, FIRST MANHATTAN CO. LLC., RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used